Recent advances on biodegradable polymeric carrier-based mucosal immunization: an overview

Artif Cells Nanomed Biotechnol. 2018 May;46(3):452-464. doi: 10.1080/21691401.2017.1345927. Epub 2017 Jul 7.

Abstract

Mucosal administration of vaccine is most prevalent way to induce desired immunity against various types of antigen and microbial in central and in addition, the peripheral blood in most external mucosal surface. Mucosal delivery of vaccine provides both humoral and cellular responses against mucosal infection. Mucosa, which are exposed to heavy loads of commensal and pathogenic microorganism, are one of the main region where infections are built up, also, thus have frontline status in immunity, making mucosa perfect site for vaccines application. The nasal route is favoured over parenteral route due to ease of administration, protection of antigen from degradation and induces sIgA which is not produced by systemic immunity. Natural and synthetic polymers are utilized to get nanoparticles carrier systems for development of nasal mucosal antibodies. The present review summarized the recent development in the field of vaccine delivery by means of mucoadhesive polymeric carriers. This review also describes the recent patent conceded for mucosal immunization utilizing these polymeric carriers.

Keywords: Mucosal delivery; humoral and cellular responses; nanoparticles; nasal route; sIgA.

Publication types

  • Review

MeSH terms

  • Animals
  • Biodegradable Plastics / therapeutic use*
  • Drug Carriers / therapeutic use*
  • Humans
  • Immunity, Mucosal / drug effects*
  • Immunization / methods*
  • Immunoglobulin A, Secretory / immunology
  • Nanoparticles / therapeutic use*
  • Nasal Mucosa / immunology*

Substances

  • Biodegradable Plastics
  • Drug Carriers
  • Immunoglobulin A, Secretory